基于Venetoclax的救援疗法用于复发/耐药急性淋巴细胞白血病的成年患者
Jonathan Canaani1, Avraham Frisch2, Daniel A Pollyea3
1Hematology Division, Chaim Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel.
European journal of haematology
|May 31, 2023
概括
威尼托克拉克斯的组合疗法在复发性/耐药性急性淋巴细胞白血病 (ALL) 中显示出有效性. 无论是venetoclax-化疗还是venetoclax-navitoclax疗法,在ALL患者中都实现了良好的反应率,并具有可控的毒性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- BCL-2家族蛋白质的失调与急性淋巴细胞白血病 (ALL) 有关.
- 在ALL中,白血病克隆通常会对特定的BCL-2家族成员产生依赖.
- 准BCL-2家族蛋白质为ALL提供了一个潜在的治疗策略.
研究的目的:
- 评估基于venetoclax的组合药物的疗效和安全性,用于复发性/耐药性 (r/r) B或T ALL的患者.
- 评估两种不同的venetoclax组合疗法:venetoclax与化疗和venetoclax与navitoclax,vincristine和asparaginase.
主要方法:
- 一项多中心回顾性队列研究包括17名患有r/r B或T ALL的患者.
- 9名患者接受了venetoclax与化疗相结合.
- 13名患者接受了与纳维托克拉克斯,温克里斯和阿斯巴拉金酶联合使用的venetoclax;五名患者之前曾接触过venetoclax.
主要成果:
- 总体响应率 (ORR) 为venetoclax-化疗的55%,为venetoclax-navitoclax组合的46%.
- 在这两组中,大多数受试者都接受了异构骨髓移植.
- 感染性并发症和肝毒性是使用venetoclax-navitoclax疗法的最常见不良事件.
结论:
- 基于Venetoclax的化疗在治疗复发性/耐药性ALL时显示出潜在的疗效.
- 韦尼托克拉克斯与纳维托克拉克斯的组合也显示出希望,尽管具有显著的传染性和肝毒性.
- 这些发现支持对r/rALL中含有venetoclax的疗法进行调查.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Bone Marrow Sampling and Transplants
364
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
364
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

